MicroPort CardioFlow IPO: Valuation Insights
MicroPort aims to raise total net proceeds of $290 million at the mid-point of the IPO price range of HK$11.10-12.20 per share. Overall, we think...
355 Views
MicroPort Cardioflow (微创心通) Pre-IPO: Thoughts on Valuation
We are taking a close look at the Microport Cardioflow’s valuation. We are of the view that the company’s fair value should be around USD 3.0 billion.
398 Views
Venus Medtech (启明医疗) & Peijia Medical (沛嘉医疗) Placement - Take Your Pick
Venus MedTech (2500 HK) is looking to raise up to US$187m in its primary placement. At the same time, Peijia Medical (9996 HK) is looking to raise...
378 Views
MicroPort CardioFlow IPO Initiation: To Save a Life
MicroPort is pre-marketing for an HK IPO to raise $300 million. With a large addressable market opportunity and VitaFlow’s potentially best-in...
845 Views
MicroPort Cardioflow (微创心通) Pre-IPO: Strong Sales Ramp-Up Despite Being Late in Market
The company's first-generation TAVR, VitaFlow, has decent clinical data in terms of efficacy and safety. It was launched two years behind VenusA...
381 Views